motortion films / Shutterstock.com
20 May 2019AmericasJohn H. Heithaus and Gerald M. Murphy
Antibody patents: Danger ahead for biologics
In recent years, the written description requirements at the US Patent and Trademark Office (USPTO) for broadly claiming antibodies have been significantly raised. These heightened requirements follow a series of cases by the Court of Appeals for the Federal Circuit (CAFC) over the last few years.
